FDA label bdabd0b3-8130-4034-a23a-376c48054748

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
e6d44cdd-40a0-4442-93f9-5a5451d84af1
SPL ID
bdabd0b3-8130-4034-a23a-376c48054748
Version
2
Effective date
2011-06-23
Source export date
2026-10-12
Source partition
2
Source file
https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/4760f38f2bcb10aa20ddbadb42b270d31e9f2a8024440d3af3dec8d11feb92ec/drug-label-0002-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 01:30:25

Boxed warning cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Boxed warning sections page 1 of 1 · 1 matching rows.

boxed warning

BOXED WARNING WARNING – Skin disinfection is required before and after application See full prescribing information for complete boxed warning. •Skin disinfection is required before and after injection. ( 5 )

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings and cautions

5. WARNINGS AND PRECAUTIONS 5.1. Be sure to disinfect the area before application. After treatment, avoid alcohol containing disinfectants as they produce local irritation that appears unpleasant on face. In most cases, the slight irritation disappears within 2 hours. 5.2. Skin cleansing/disinfection is required before application. Saprophytic bacteria may produce injection site abscesses with improper skin preparation. Skin cleansing: •Be sure to disinfect the area before application. After treatment, avoid alcohol-containing disinfectants as they produce local irritation that appears unpleasant on the face. In most cases, the slight irritation disappears within 2 hours. •Saprophytic bacteria (i.e. atypical mycobacteria, staphylococcus genus) may be present on skin or in makeup products. When injection treatments are performed, bacteria introduced beneath the skin may produce local infection (injection site abscesses), which appear as little red spots. Skin disinfection helps prevent this problem. ( 5 )

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

6. ADVERSE REACTIONS 6.1. The most common mild adverse reaction is slight reddening at the injection site due to the mechanical effect of the needle or a superficial skin reaction of mild erythema. The most common mild adverse reaction is slight reddening at the injection site due to the mechanical effects of the needle or a superficial skin reaction of mild erythema. To report SUSPECTED ADVERSE REACTIONS, contact GUNA Inc. at 1-888-GUNA-TEL (4862-835) or www.gunainc.com Or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. ( 6 )

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.